Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study - Concepedia

Concepedia

Publication | Open Access

Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study

DOI Full Paper Access

57

Citations

24

References

2020

Year

Joris R. de Groot, Thomas W. Weiss, Peter J. Kelly, Pedro Monteiro, Jean‐Claude Deharo, Carlo de Asmundis, Esteban López de Sá, Johannes Waltenberger, Jan Steffel, Pierre Lévy,

European Heart Journal - Cardiovascular Pharmacotherapy

Abstract

The rates of stroke, systemic embolism, and major bleeding are low in this large unselected cohort of high-risk AF patients routinely treated with edoxaban.

References

	Year	Citations

Page 1